Source link : https://www.newshealth.biz/health-news/car-t-plus-stem-cell-transplant-promising-for-cd7-blood-cancers/
A strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical hematopoietic stem-cell transplantation (HSCT), without graft-versus-host disease (GVHD) prophylaxis, is a feasible approach for patients with relapsed or refractory hematologic cancers who are ineligible for conventional allogeneic HSCT, Chinese researchers said. After CAR T-cell therapy, all 10 patients in their case series […]
Author : News Health
Publish date : 2024-04-24 21:00:00
Copyright for syndicated content belongs to the linked Source.